" MR imaging" . . . . . . "http://www.isvav.cz/projectDetail.do?rowId=NR7853"^^ . "Metody MR jater a mozku p\u0159i 1,5 T u pacient\u016F s chronickou hepatitidou C odli\u0161it a\u017E pokro\u010Dilej\u0161\u00ED stadia jatern\u00EDho po\u0161kozen\u00ED. Nelze odli\u0161it jednotliv\u00E9 stupn\u011B fibrotizace a vliv encefalopatie. Nebyla zji\u0161t\u011Bna vazba na p\u0159\u00EDtomnost viru hepatitidy C."@cs . . . . " liver cirrhosis" . "C\u00EDlem projektu je porovn\u00E1n\u00ED klinick\u00FDch a MR dat (1H a 31P MR spekter, T1 a T2 v\u00E1\u017Een\u00FDch obraz\u016F) z oblasti jater a mozku nemocn\u00FDch s hepatitidou C a tak p\u0159isp\u011Bt k neinvazivn\u00EDmu hodnocen\u00ED klinick\u00E9ho stavu t\u011Bchto pacient\u016F a navr\u017Een\u00ED vhodn\u00E9ho typu l\u00E9\u010Dby. Z metod MR budou pou\u017Eity metody 1H a 31P MR spektroskopie, MR relaxometrie a anal\u00FDza textury z klasick\u00FDch T2 a T1 v\u00E1\u017Een\u00FDch MR obraz\u016F. Z\u00EDskan\u00E1 MR data budou korelov\u00E1na s v\u00FDsledky laboratorn\u00EDch a klinick\u00FDch metod." . " texture analysis" . . " 31P MR spectroscopy" . . "Hepatitis C" . "0"^^ . . "NR7853" . "MR methodsat 1,5 T can distinguish only advanced status of the liver disease in patiens with chronic hepatitis C. It is not possible to separate single fibrosis stages and encephalopathy effect. No dependence on the HCV-RNA virus presence was found."@en . "Hepatitis C; liver cirrhosis; 31P MR spectroscopy; texture analysis; MR imaging; persistent hepatitis"@en . . "Noninvasive hepatitis C virus detection in liver and brain by 31 MR spectroscopy"@en . . "1"^^ . "0"^^ . "1"^^ . . "1"^^ . . . . "Neinvazivn\u00ED sledov\u00E1n\u00ED p\u0159\u00EDtomnosti viru hepatitidy C v j\u00E1trech a mozku a jeho ovlivn\u011Bn\u00ED l\u00E9\u010Dbou." . . "2007-08-08+02:00"^^ . . "The project objective is the correlation between clinical and MR data of the liver and brain in patients with hepatitis C and thus make a contribution to clinical evaluation of those patients and to an appropriate treatment plan proposal. 1H and 31P MR spectroscopy, MR relaxometry and texture analysis of T1 and T2-weighted MR images will be done. Obtained MR data will be correlated with clinical, laboratory and pathological findings."@en . . .